Prot #PrE0905: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)

Project: Research project

Project Details

StatusFinished
Effective start/end date1/30/20 → 1/30/23

Funding

  • Alpha Oncology, Inc. (Prot #PrE0905)
  • PrECOG, LLC (Prot #PrE0905)